Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
about
Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trialProspective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and TanzaniaPharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.Use of quantitative pharmacology tools to improve malaria treatments.Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis
P2860
Q28542921-49C8905F-2366-488E-AF7A-1351354E7BDFQ35519260-771FA61C-3982-4DEE-9893-88A9E7E3A180Q35746024-626FF227-4322-407A-9860-E9C3CB146B34Q35746240-C4BE435C-F8C2-4D61-A85D-6F4956D3EC9CQ36075783-70D1BA92-5C2F-4B84-996F-CE095D89951EQ37120112-5E4FDC3A-F429-41C4-AEDB-03F9EAF9B2A6Q38664529-6ECB954D-9992-49C5-BE9B-E4443EA36305Q38684764-F1E3DD71-FE1B-41F0-83CD-D5B2F8C4694EQ46405195-C8F8472C-6BD5-43C6-94F8-0CEADD25ABFFQ47143596-6639D7C9-A19B-4AB2-A375-E5EFE4696A16Q56352635-AC71B35B-B1AA-4A64-B7CB-2F22192F8A44
P2860
Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of coadministered fat o ...... en with uncomplicated malaria.
@ast
Effect of coadministered fat o ...... en with uncomplicated malaria.
@en
Effect of coadministered fat o ...... en with uncomplicated malaria.
@nl
type
label
Effect of coadministered fat o ...... en with uncomplicated malaria.
@ast
Effect of coadministered fat o ...... en with uncomplicated malaria.
@en
Effect of coadministered fat o ...... en with uncomplicated malaria.
@nl
prefLabel
Effect of coadministered fat o ...... en with uncomplicated malaria.
@ast
Effect of coadministered fat o ...... en with uncomplicated malaria.
@en
Effect of coadministered fat o ...... en with uncomplicated malaria.
@nl
P2093
P2860
P356
P1476
Effect of coadministered fat o ...... ren with uncomplicated malaria
@en
P2093
J M Benjamin
L J Robinson
M Page-Sharp
P2860
P304
P356
10.1128/AAC.03314-14
P407
P577
2014-07-21T00:00:00Z